Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Cronos Group Inc (CRON) – Cronos Group Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

CRON trades at $2.645, showing minimal daily change. The technical outlook is bullish based on moving averages, though oscillators are neutral. Revenue growth is strong, with 2025 full-year revenue reaching $146.6 million (Cronos Group Reports, 2026-02-26), but profitability remains a challenge with a negative net income margin. Recent news highlights expansion efforts and a record annual revenue performance.
The stock presents a mixed outlook. Growth potential exists from geographic expansion and product launches, but persistent net losses and a cautious analyst consensus (60% hold rating) signal risk. Investment appeal hinges on the company's ability to translate revenue growth into sustained profitability amid competitive and regulatory pressures.
Read full analysis

Key Stats

  • Market Cap
    $1.00B
  • Sector
    Health
  • 3M Drawdown
    -13.72%
  • Enterprise Value
    $174.03M
  • Dividend Yield
    -
  • Typical Hold Time
    18 days
$2.65
52W Low: $1.85
07 May 2025
52W High: $3.27
12 Dec 2025

Cronos Group Inc (CRON) is currently valued at a market capitalization of $1.00B, with an enterprise value of $174.03M. Over the past 52 weeks, Cronos Group Inc has traded between a low of $1.85 and a high of $3.27, highlighting its annual price range. Over the past three months, Cronos Group Inc has recorded a drawdown of -13.72%, reflecting recent price volatility. On average, investors hold Cronos Group Inc for approximately 18 days, indicating typical investor behavior on the platform.

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.


Technical Indicators
|
|
|
Overall Summary
Bearish (16)Neutral (4)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.00B
  • Sector
    Health
  • 3M Drawdown
    -13.72%
  • Enterprise Value
    $174.03M
  • Dividend Yield
    -
  • Typical Hold Time
    18 days
$2.65
52W Low: $1.85
07 May 2025
52W High: $3.27
12 Dec 2025

Cronos Group Inc (CRON) is currently valued at a market capitalization of $1.00B, with an enterprise value of $174.03M. Over the past 52 weeks, Cronos Group Inc has traded between a low of $1.85 and a high of $3.27, highlighting its annual price range. Over the past three months, Cronos Group Inc has recorded a drawdown of -13.72%, reflecting recent price volatility. On average, investors hold Cronos Group Inc for approximately 18 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!